REFILE-UPDATE 1-China's COVID-19 vaccine candidate shows promise in human trials, CNBG says
China National Biotec Group (CNBG) said on Tuesday its experimental coronavirus vaccine has triggered antibodies in clinical trials and the company plans late-stage human trials in foreign countries. [Source]
Publication Date:Origin: reuters.com
Category: companyNews
Topics: trials, human, countries, foreign, late-stage, plans, the company, clinical, antibodies, triggered, coronavirus vaccine, experimental, (CNBG), Biotec Group, National, China, promise, shows, candidate, vaccine, COVID-19, 1-China's, REFILE-UPDATE